Amplification and overexpression of the ABCC3 (MRP3) gene in primary breast cancer

Genes, Chromosomes & Cancer
Laura PartanenJorma Isola

Abstract

The ATP-binding cassette (ABC) of active transporters comprises a group of proteins that which facilitate efflux of anticancer drugs from cancer cells. We focused on the gene amplification and protein expression of ABCC3 (also known as MRP3) in breast cancer cell lines and clinical tumor samples. Fluorescence and chromogenic in situ hybridization, using an ABCC3-specific probe, was used to analyze 11 breast cancer cell lines and 112 clinical tumor samples. The results of ABCC3 were correlated with the amplification status of HER2 and topoisomerase II alpha (TOP2A), which are located close to ABCC3 at 17q12-q21. Immunohistochemistry was used to assess ABCC3 protein overexpression. Of the cell lines studied 6 HER2-positive lines and 1 HER2-negative line exhibited amplification of ABCC3. In the HER-2-negative clinical tumor samples, only 4/55 (7.3%) exhibited ABCC3 amplification. In the HER2-positive tumors, ABCC3 was amplified in 16/57 tumors (28.1%, P=0.0059). TOP2A did not exhibit any consistent coamplification pattern. ABCC3 (MRP3) protein overexpression was more common in tumors with gene amplification (P=0.069). In silico analysis of 804 breast cancers with matched gene expression and copy number microarray data revealed sig...Continue Reading

References

Jun 9, 1999·Proceedings of the National Academy of Sciences of the United States of America·M KoolP Borst
Aug 17, 2000·Journal of the National Cancer Institute·P BorstJ Wijnholds
Jun 5, 2002·Annual Review of Biochemistry·P Borst, R Oude Elferink
Jul 23, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jorma IsolaJohn M S Bartlett
Mar 7, 2006·Nature Reviews. Drug Discovery·Gergely SzakácsMichael M Gottesman
Apr 6, 2006·Pflügers Archiv : European journal of physiology·Piet BorstKoen van de Wetering
Nov 14, 2007·Cell Cycle·Piet BorstSven Rottenberg
Nov 14, 2007·Journal of Digital Imaging·Vilppu J Tuominen, Jorma Isola
Feb 11, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joel S ParkerPhilip S Bernard
Jul 2, 2009·Clinical and Experimental Pharmacology & Physiology·Ya-He LiuShu-Feng Zhou
Jan 21, 2010·Cancer Chemotherapy and Pharmacology·April DavoliThomas L Brown
Jan 27, 2010·Cancer Treatment Reviews·R W GlynnM J Kerin
Dec 22, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Howard A BurrisJoyce A O'Shaughnessy
Dec 30, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael F PressDennis J Slamon

❮ Previous
Next ❯

Citations

Oct 12, 2012·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Y ChengL Liu
Apr 4, 2015·Expert Opinion on Drug Metabolism & Toxicology·Helena JoyceAnnemarie Larkin
Feb 18, 2016·Oxidative Medicine and Cellular Longevity·Aysegul CortLiudmila Korkina
Jan 7, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Xuejun LiuDuo Liu
Jun 24, 2015·Critical Reviews in Oncology/hematology·M P WeenC Ricciardelli
Oct 3, 2013·Asian Pacific Journal of Cancer Prevention : APJCP·Jie YangYun-Lan Xu
Sep 5, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Gabriela Carrasco-TorresVerónica Rocío Vásquez-Garzón
Aug 1, 2014·Biochimica Et Biophysica Acta·Mafalda VideiraMaria Alexandra Brito
May 14, 2016·PloS One·Sai A BalajiAnnapoorni Rangarajan
Aug 2, 2019·Applied Biochemistry and Biotechnology·Ya WangYonggang Lv

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.